UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL people

Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Type | Date
Number of items: 807.

Article

Abdel-Aziz, K; Schneider, T; Solanky, BS; Yiannakas, MC; Altmann, DR; Wheeler-Kingshott, CAM; Peters, AL; Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Brain

Abdel-Aziz, K; Solanky, BS; Yiannakas, MC; Altmann, DR; Wheeler-Kingshott, CA; Thompson, AJ; Ciccarelli, O; (2014) Age related changes in metabolite concentrations in the normal spinal cord. PLoS One , 9 (10) , Article e105774. 10.1371/journal.pone.0105774. Green open access
file

Aguirregomozcorta, M; Mancini, L; Jenkins, TM; Hickman, SJ; Ciccarelli, O; Plant, GT; Thompson, AJ; (2011) A longitudinal functional MRI study of non-arteritic anterior ischaemic optic neuropathy patients. J NEUROL NEUROSUR PS , 82 (8) 905 - 913. 10.1136/jnnp.2009.194563.

Altmann, DR; Jasperse, B; Barkhof, F; Beckmann, K; Filippi, M; Kappos, LD; Molyneux, P; (2009) Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. NEUROLOGY , 72 (7) 595 - 601.

Altmann, DR; Miszkiel, KA; Thompson, AJ; (2009) Gray Matter Atrophy Is Related to Long-Term Disability in Multiple Sclerosis (vol 64, pg 247, 2008). ANN NEUROL , 65 (2) 232 - 232. 10.1002/ana.21570.

Amato, MP; Grimaud, J; Achiti, I; Bartolozzi, ML; Adeleine, P; Hartung, HP; Kappos, L; (2004) European validation of a standardized clinical description of multiple sclerosis. J NEUROL , 251 (12) 1472 - 1480. 10.1007/s00415-004-0567-0.

Amato, MP; Langdon, D; Montalban, X; Benedict, RHB; Deluca, J; Krupp, LB; Thompson, AJ; (2013) Treatment of cognitive impairment in multiple sclerosis: Position paper. Journal of Neurology , 260 (6) 1452 - 1468. 10.1007/s00415-012-6678-0.

Anderson, VM; Fisniku, LK; Altmann, DR; Thompson, AJ; Miller, DH; (2009) MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction. MULT SCLER , 15 (7) 811 - 817. 10.1177/1352458508101934.

Anderson, VM; Fisniku, LK; Khaleeli, Z; Summers, MM; Penny, SA; Altmann, DR; Thompson, AJ; (2010) Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. MULT SCLER , 16 (9) 1083 - 1090. 10.1177/1352458510374893.

Anderson, VM; Wheeler-Kingshott, CAM; Abdel-Aziz, K; Miller, DH; Toosy, A; Thompson, AJ; Ciccarelli, O; (2011) A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis. MULT SCLER J , 17 (9) 1079 - 1087. 10.1177/1352458511403528.

Antel, J; Carroll, W; Thompson, A; (2009) Reflections on 2008. Multiple Sclerosis , 15 (1) 1 - 1. 10.1177/1352458508101037.

Antel, J; Carroll, W; Thompson, A; (2008) Untitled. MULT SCLER , 14 (9) 1153 - 1153. 10.1177/1352458508098093.

Antel, J; Thompson, A; Carroll, W; (2010) Chronic cerebrospinal venous insufficiency. MULT SCLER , 16 (7) 770 - 770. 10.1177/1352458510374342.

Audoin, B; Davies, G; Rashid, W; Fisniku, L; Thompson, AJ; Miller, DH; (2007) Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis. MULT SCLER , 13 (4) 483 - 489. 10.1177/1352458506070450.

Audoin, B; Davies, GR; Finisku, L; Chard, DT; Thompson, AJ; Miller, DH; (2006) Localization of grey matter atrophy in early RRMS - A longitudinal study. J NEUROL , 253 (11) 1495 - 1501. 10.1007/s00415-006-0264-2.

Audoin, B; Fernando, KTM; Swanton, JK; Thompson, AJ; Plant, GT; Miller, DH; (2006) Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. BRAIN , 129 1031 - 1039. 10.1093/brain/awl039.

BARKHOF, F; THOMPSON, AJ; KAPPOS, L; NAUTA, JJP; YOUSRI, T; BERRY, I; SCOTTI, G; (1993) DATABASE FOR SERIAL MAGNETIC-RESONANCE-IMAGING IN MULTIPLE-SCLEROSIS. NEURORADIOLOGY , 35 (5) 362 - 366.

BARRY, R; LAWRENCE, M; THOMPSON, A; MCDONALD, I; GROOME, N; (1990) AN IMPROVED RADIOIMMUNOASSAY FOR MYELIN BASIC PROTEIN-LIKE IMMUNOREACTIVE MATERIAL IN CEREBROSPINAL-FLUID. NEUROCHEM INT , 16 (4) 549 - 558.

BROWN, MM; THOMPSON, AJ; WEDZICHA, JA; SWASH, M; (1989) SARCOIDOSIS PRESENTING WITH STROKE. STROKE , 20 (3) 400 - 405.

Baker, D; Pryce, G; Giovannoni, G; Thompson, AJ; (2003) The therapeutic potential of cannabis. LANCET NEUROL , 2 (5) 291 - 298.

Bakshi, R; Thompson, AJ; Rocca, MA; Pelletier, D; Dousset, V; Barkhof, F; Inglese, M; (2008) MRI in multiple sclerosis: current status and future prospects. LANCET NEUROL , 7 (7) 615 - 625.

Barkhof, F; Filippi, M; Miller, DH; Tofts, P; Kappos, L; Thompson, AJ; (1997) Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J NEUROL , 244 (2) 76 - 84.

Barkhof, F; Van Waesberghe, J-HTM; Polman, CH; Filippi, M; Yousry, T; Miller, DH; Thompson, AJ; (2001) T hypointense lesions in secondary progressive multiple sclerosis: Effect of interferon beta-1b treatment. Brain , 124 (7) 1396 - 1402.

Barkhof, F; van Waesberghe, JHTM; Filippi, M; Yousry, T; Miller, DH; Hahn, D; Thompson, AJ; (2001) T-1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. BRAIN , 124 1396 - 1402.

Behrens, T.E.J.; Johansen-Berg, H.; Woolrich, M.W.; Smith, S.M.; Wheeler-Kingshott, C.A.M.; Boulby, P.A.; Barker, G.J.; (2003) Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nature Neuroscience , 6 (7) pp. 750-757. 10.1038/nn1075.

Behrens, TEJ; Johansen-Berg, H; Woolrich, MW; Smith, SM; Wheeler-Kingshott, CAM; Boulby, PA; Barker, GJ; (2003) Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. NAT NEUROSCI , 6 (7) 750 - 757. 10.1038/nn1075.

Bieniek, M; Altmann, DR; Davies, GR; Ingle, GT; Rashid, W; Sastre-Garriga, J; Thompson, AJ; (2006) Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J NEUROL NEUROSUR PS , 77 (9) 1036 - 1039. 10.1136/jnnp.2006.094748. Gold open access

Bodini, B; Battaglini, M; De Stefano, N; Khaleeli, Z; Barkhof, F; Chard, D; Filippi, M; (2011) T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 82 (1) 72 - 77. 10.1136/jnnp.2009.201574. Gold open access

Bodini, B; Cercignani, M; Khaleeli, Z; Miller, DH; Ron, M; Penny, S; Thompson, AJ; (2013) Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years. Hum Brain Mapp , 34 (5) 1163 - 1172. 10.1002/hbm.21499.

Bodini, B; Cercignani, M; Toosy, A; De Stefano, N; Miller, DH; Thompson, AJ; Ciccarelli, O; (2014) A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS. Hum Brain Mapp , 35 (2) 723 - 733. 10.1002/hbm.22196.

Bodini, B; Khaleeli, Z; Cercignani, M; Miller, DH; Thompson, AJ; Ciccarelli, O; (2009) Exploring the Relationship Between White Matter and Gray Matter Damage in Early Primary Progressive Multiple Sclerosis: An In Vivo Study With TBSS and VBM. HUM BRAIN MAPP , 30 (9) 2852 - 2861. 10.1002/hbm.20713.

Bodini, B; Toosy, A; Thompson, AJ; Ciccarelli, O; Cercignani, M; Stefano, ND; Miller, DH; (2014) A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS. Human Brain Mapping , 35 (2) 723 - 733. 10.1002/hbm.22196.

Bonati, U; Fisniku, LK; Altmann, DR; Yiannakas, MC; Furby, J; Thompson, AJ; Miller, DH; (2011) Cervical cord and brain grey matter atrophy independently associate with long-term MS disability. J NEUROL NEUROSUR PS , 82 (4) 471 - 472.

Bosma, LVAE; Kragt, JJ; Brieva, L; Khaleeli, Z; Montalban, X; Polman, CH; Thompson, AJ; (2010) Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components? MULT SCLER , 16 (7) 862 - 867. 10.1177/1352458510370464.

Bosma, LVAE; Kragt, JJ; Brieva, L; Khaleeli, Z; Montalban, X; Polman, CH; Thompson, AJ; (2009) The search for responsive clinical endpoints in primary progressive multiple sclerosis. MULT SCLER , 15 (6) 715 - 720. 10.1177/1352458509102626.

Bosnell, R; Wegner, C; Kincses, ZT; Korteweg, T; Agosta, F; Ciccarelli, O; De Stefano, N; (2008) Reproducibility of fMRI in the clinical setting: Implications for trial designs. NEUROIMAGE , 42 (2) 603 - 610. 10.1016/j.neuroimage.2008.05.005.

Brex, P.A.; Ciccarelli, O.; O'Riordan, J.I.; Sailer, M.; Thompson, A.J.; Miller, D.H.; (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. New England Journal of Medicine , 346 (3) pp. 158-164. 10.1056/NEJMoa011341. Green open access
file

Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH; (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. NEW ENGL J MED , 346 (3) 158 - 164.

Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH; (2001) Relation between serial MRI and the development of disability in patients with clinically isolated syndromes suggestive of multiple sclerosis. J NEUROL NEUROSUR PS , 71 (3) 423 - 423.

Brex, PA; Leary, SM; O'Riordan, JI; Miszkiel, KA; Plant, GT; Thompson, AJ; Miller, DH; (2001) Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis. J NEUROL NEUROSUR PS , 70 (4) 544 - 547.

Brex, PA; Leary, SM; Plant, GT; Thompson, AJ; Miller, DH; (2001) Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. AM J NEURORADIOL , 22 (5) 947 - 951.

Brex, PA; Miszkiel, KA; O'Riordan, JI; Plant, GT; Moseley, IF; Thompson, AJ; Miller, DH; (2001) Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J NEUROL NEUROSUR PS , 70 (3) 390 - 393.

Brex, PA; Molyneux, PD; Smiddy, P; Barkhof, F; Filippi, M; Yousry, TA; Hahn, D; (2001) The effect of IFN beta-1b on the evolution of enhancing lesions in secondary progressive MS. NEUROLOGY , 57 (12) 2185 - 2190.

Brex, PA; O'Riordan, JI; Miszkiel, KA; Moseley, IF; Thompson, AJ; Plant, GT; Miller, DH; (1999) Multisequence MRI in clinically isolated syndromes and the early development of MS. NEUROLOGY , 53 (6) 1184 - 1190.

Brex, PA; Parker, GJM; Leary, SM; Molyneux, PD; Barker, GJ; Davie, CA; Thompson, AJ; (2000) Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J NEUROL NEUROSUR PS , 68 (5) 627 - 632.

Brown, MM; Thompson, A; Goh, BT; Forster, GE; Swash, M; (1988) Bell's palsy and HIV infection. J Neurol Neurosurg Psychiatry , 51 (3) 425 - 426.

Browne, P; Chandraratna, D; Angood, C; Tremlett, H; Baker, C; Taylor, BV; Thompson, AJ; (2014) Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology , 83 (11) 1022 - 1024. 10.1212/WNL.0000000000000768.

CADOUXHUDSON, TAD; KERMODE, A; RAJAGOPALAN, B; TAYLOR, D; THOMPSON, AJ; ORMEROD, IEC; MCDONALD, WI; (1991) BIOCHEMICAL-CHANGES WITHIN A MULTIPLE-SCLEROSIS PLAQUE INVIVO. J NEUROL NEUROSUR PS , 54 (11) 1004 - 1006.

COCKBURN, F; BARWELL, B; BRENTON, D; CHAPPLE, J; CLARK, B; CURZON, G; DAVIDSON, D; (1993) PHENYLKETONURIA DUE TO PHENYLALANINE-HYDROXYLASE DEFICIENCY - AN UNFOLDING STORY. BRITISH MEDICAL JOURNAL , 306 (6870) 115 - 119.

CONFAVREUX, C; COMPSTON, DAS; HOMMES, OR; MCDONALD, WI; THOMPSON, AJ; (1992) EDMUS, A EUROPEAN DATABASE FOR MULTIPLE-SCLEROSIS. J NEUROL NEUROSUR PS , 55 (8) 671 - 676.

Camp, SJ; Stevenson, VL; Thompson, AJ; Ingle, GT; Miller, DH; Borras, C; Brochet, B; (2005) A longitudinal study of cognition in primary progressive multiple sclerosis. BRAIN , 128 2891 - 2898. 10.1093/brain/awh602.

Camp, SJ; Stevenson, VL; Thompson, AJ; Miller, DH; Borras, C; Auriacombe, S; Brochet, B; (1999) Cognitive function in primary progressive and transitional progressive multiple sclerosis - A controlled study with MRI correlates. BRAIN , 122 1341 - 1348.

Camp, SJ; Thompson, AJ; Langdon, DW; (2001) A new test of memory for multiple sclerosis I: Format development and stimuli design. MULT SCLER , 7 (4) 255 - 262.

Cano, SJ; Hobart, JC; Edwards, M; Fitzpatrick, R; Bhatia, K; Thompson, AJ; Warner, TT; (2006) CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. NEUROLOGY , 67 (12) 2230 - 2232.

Cano, SJ; Hobart, JC; Fitzpatrick, R; Bhatia, K; Thompson, AJ; Warner, TT; (2004) Patient-based outcomes of cervical dystonia: A review of rating scales. MOVEMENT DISORD , 19 (9) 1054 - 1059. 10.1002/mds.20055.

Cano, SJ; O'Connor, RJ; Thompson, AJ; Hobart, JC; (2006) Exploring disability rating scale responsiveness II: Do more response options help? NEUROLOGY , 67 (11) 2056 - 2059.

Cano, SJ; Thompson, AJ; Bhatia, K; Fitzpatrick, R; Warner, TT; Hobart, JC; (2007) Evidence-based guidelines for using the short form 36 in cervical dystonia. MOVEMENT DISORD , 22 (1) 122 - 126. 10.1002/mds.21187.

Cano, SJ; Warner, TT; Linacre, JM; Bhatia, KP; Thompson, AJ; Fitzpatrick, R; Hobart, JC; (2004) Capturing the true burden of dystonia on patients - The Cervical Dystonia Impact Profile (CDIP-58). NEUROLOGY , 63 (9) 1629 - 1633.

Cano, SJ; Warner, TT; Thompson, AJ; Bhatia, KP; Fitzpatrick, R; Hobart, JC; (2008) The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria? HEALTH QUAL LIFE OUT , 6 , Article 58. 10.1186/1477-7525-6-58. Gold open access

Chard, DT; Brex, PA; Ciccarelli, O; Griffin, CM; Parker, GJM; Dalton, C; Altmann, DR; (2003) The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. J NEUROL NEUROSUR PS , 74 (11) 1551 - 1554.

Chard, DT; Brex, PA; Ciccarelli, O; Griffin, CMB; Dalton, C; Thompson, AJ; Miller, DH; (2002) The predictive value of brain lesion load in determining brain atrophy in multiple sclerosis: 14 year follow up data following first presentation with a clinically isolated syndrome. J NEUROL NEUROSUR PS , 73 (2) 214 - 214.

Chard, DT; Dalton, CM; Swanton, J; Fisniku, LK; Miszkiel, KA; Thompson, AJ; Plant, GT; (2011) MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J NEUROL NEUROSUR PS , 82 (2) 176 - 179. 10.1136/jnnp.2010.208660.

Chard, DT; Griffin, CM; McLean, MA; Kapeller, P; Kapoor, R; Thompson, AJ; Miller, DH; (2002) Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. BRAIN , 125 2342 - 2352.

Chard, DT; Griffin, CM; Parker, GJM; Kapoor, R; Thompson, AJ; Miller, DH; (2002) Brain atrophy in clinically early relapsing-remitting multiple sclerosis. BRAIN , 125 327 - 337.

Chard, DT; Griffin, CM; Rashid, W; Davies, GR; Altmann, DR; Kapoor, R; Barker, GJ; (2004) Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. MULT SCLER , 10 (4) 387 - 391. 10.1191/1352458504ms1050oa.

Chard, DT; Parker, GJM; Griffin, CMB; Thompson, AJ; Miller, DH; (2002) The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. JOURNAL OF MAGNETIC RESONANCE IMAGING , 15 (3) 259 - 267. 10.1002/jmri.10064.

Chataway, J; Porter, B; Riazi, A; Heaney, D; Watt, H; Hobart, J; Thompson, A; (2006) Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. LANCET NEUROL , 5 (7) 565 - 571. 10.1016/S1474-4422(06)70450-1.

Chataway, J.; Porter, B.; Riazi, A.; Heaney, D.; Watt, H.; Hobart, J.; Thompson, A.; (2006) Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. The Lancet Neurology , 5 (7) pp. 565-571. 10.1016/S1474-4422(06)70450-1.

Ciccarelli, O; Altmann, DR; McLean, MA; Wheeler-Kingshott, CA; Wimpey, K; Miller, DH; Thompson, AJ; (2010) Spinal cord repair in MS Does mitochondrial metabolism play a role? NEUROLOGY , 74 (9) 721 - 727. 10.1212/WNL.0b013e3181d26968. Gold open access

Ciccarelli, O; Behrens, TE; Altmann, DR; Orrell, RW; Howard, RS; Johansen-Berg, H; Miller, DH; (2006) Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. BRAIN , 129 1859 - 1871. 10.1093/brain/awl100.

Ciccarelli, O; Behrens, TE; Johansen-Berg, H; Talbot, K; Orrell, RW; Howard, RS; Nunes, RG; (2009) Investigation of White Matter Pathology in ALS and PLS Using Tract-Based Spatial Statistics. HUM BRAIN MAPP , 30 (2) 615 - 624. 10.1002/hbm.20527.

Ciccarelli, O; Brex, PA; Thompson, AJ; Miller, DH; (2002) Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. J NEUROL , 249 (1) 18 - 24.

Ciccarelli, O; Catani, M; Johansen-Berg, H; Clark, C; Thompson, A; (2008) Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. LANCET NEUROL , 7 (8) 715 - 727.

Ciccarelli, O; Parker, GJM; Toosy, AT; Wheeler-Kingshott, CAM; Barker, GJ; Boulby, PA; Miller, DH; (2003) From diffusion tractography to quantitative white matter tract measures: a reproducibility study. NEUROIMAGE , 18 (2) 348 - 359. 10.1016/S1053-8119(02)00042-3.

Ciccarelli, O; Thomas, DL; De Vita, E; Wheeler-Kingshott, CA; Kachramanoglou, C; Kapoor, R; Leary, S; (2013) Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica. Ann Neurol , 74 (2) 301 - 305. 10.1002/ana.23909.

Ciccarelli, O; Toosy, AT; De Stefano, N; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; (2010) Assessing Neuronal Metabolism In Vivo by Modeling Imaging Measures. J NEUROSCI , 30 (45) 15030 - 15033. 10.1523/JNEUROSCI.3330-10.2010.

Ciccarelli, O; Toosy, AT; Hickman, SJ; Parker, GJM; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; (2005) Optic radiation changes after optic neuritis detected by tractography-based group mapping. HUM BRAIN MAPP , 25 (3) 308 - 316. 10.1002/hbm.20101.

Ciccarelli, O; Toosy, AT; Marsden, JE; Wheeler-Kingshott, CM; Miller, DH; Matthews, PM; Thompson, AJ; (2006) Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis. J NEUROL , 253 (7) 882 - 891. 10.1007/s00415-006-0125-z.

Ciccarelli, O; Toosy, AT; Marsden, JF; Wheeler-Kingshott, CM; Sahyoun, C; Matthews, PM; Miller, DH; (2005) Identifying brain regions for integrative sensorimotor processing with ankle movements. EXP BRAIN RES , 166 (1) 31 - 42. 10.1007/s00221-005-2335-5.

Ciccarelli, O; Toosy, AT; Parker, GJM; Wheeler-Kingshott, CAM; Barker, GJ; Miller, DH; Thompson, AJ; (2003) Diffusion tractography based group mapping of major white-matter pathways in the human brain. NEUROIMAGE , 19 (4) 1545 - 1555. 10.1016/S1053-8119(03)00190-3.

Ciccarelli, O; Werring, DJ; Barker, GJ; Griffin, CM; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; (2003) A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging - Evidence of Wallerian degeneration. J NEUROL , 250 (3) 287 - 292. 10.1007/s00415-003-0992-5.

Ciccarelli, O; Werring, DJ; Wheeler-Kingshott, CAM; Barker, GJ; Parker, GJM; Thompson, AJ; Miller, DH; (2001) Investigation of MS normal-appearing brain using diffusion tenser MRI with clinical correlations. NEUROLOGY , 56 (7) 926 - 933.

Ciccarelli, O; Wheeler-Kingshott, CA; McLean, MA; Cercignani, M; Wimpey, K; Miller, DH; Thompson, AJ; (2007) Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. BRAIN , 130 2220 - 2231. 10.1093/brain/awm152.

Clark, M; Playford, ED; Thompson, AJ; (2006) Adolescent neurorehabilitation. DEV MED CHILD NEUROL , 48 20 - 20.

Cohen, JA; Reingold, SC; Polman, CH; Wolinsky, JS; International Advisory Committee on Clinical Trials in Multiple Sclerosis, ; (2012) Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurol , 11 (5) 467 - 476. 10.1016/S1474-4422(12)70059-5.

Confavreux, C; Hutchinson, M; Hours, MM; Cortinovis-Tourniaire, P; Moreau, T; Pregnancy Multiple Sclerosis Grp, ; (1998) Rate of pregnancy-related relapse in multiple sclerosis. NEW ENGL J MED , 339 (5) 285 - 291.

Connick, P; Kolappan, M; Crawley, C; Webber, DJ; Patani, R; Michell, AW; Du, MQ; (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol , 11 (2) 150 - 156. 10.1016/S1474-4422(11)70305-2.

Connick, P; Kolappan, M; Patani, R; Scott, MA; Crawley, C; He, XL; Richardson, K; (2011) The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. TRIALS , 12 , Article 62. 10.1186/1745-6215-12-62. Gold open access

Cook, PA; Zhang, H; Avants, BB; Yushkevich, P; Alexander, DC; Gee, JC; Ciccarelli, O; (2005) An automated approach to connectivity-based partitioning of brain structures. Med Image Comput Assist Interv , 8 (1) 164 - 171.

Costelloe, L; Thompson, A; Walsh, C; Tubridy, N; Hutchinson, M; (2008) Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J NEUROL NEUROSUR PS , 79 (11) 1245 - 1248. 10.1136/jnnp.2008.143586.

Cutter, GR; Baier, ML; Rudick, RA; Cookfair, DL; Fischer, JS; Petkau, J; Syndulko, K; (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. BRAIN , 122 871 - 882.

Dalton, CM; Bodini, B; Samson, RS; Battaglini, M; Fisniku, LK; Thompson, AJ; Ciccarelli, O; (2012) Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler , 18 (3) 322 - 328. 10.1177/1352458511420269.

Dalton, CM; Brex, PA; Jenkins, R; Fox, NC; Miszkiel, KA; Crum, WR; O'Riordan, JI; (2002) Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J NEUROL NEUROSUR PS , 73 (2) 141 - 147.

Dalton, CM; Brex, PA; Miszkiel, KA; Fernando, K; MacManus, DG; Plant, GT; Thompson, AJ; (2003) Spinal cord MRI in clinically isolated optic neuritis. J NEUROL NEUROSUR PS , 74 (11) 1577 - 1580.

Dalton, CM; Brex, PA; Miszkiel, KA; Fernando, K; MacManus, DG; Plant, GT; Thompson, AJ; (2003) New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. ANN NEUROL , 53 (5) 673 - 676. 10.1002/ana.10580.

Dalton, CM; Brex, PA; Miszkiel, KA; Hickman, SJ; MacManus, DG; Plant, GT; Thompson, AJ; (2002) Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. ANN NEUROL , 52 (1) 47 - 53. 10.1002/ana.10240.

Dalton, CM; Brex, PA; Miszkiel, KA; Plant, GT; Hickman, SJ; MacManus, DG; Thompson, AJ; (2002) Validation of the McDonald criteria in patients with clinically isolated syndromes. J NEUROL NEUROSUR PS , 73 (2) 214 - 214.

Dalton, CM; Chard, DT; Davies, GR; Miszkiel, KA; Altmann, DR; Fernando, K; Plant, GT; (2004) Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. BRAIN , 127 1101 - 1107. 10.1093/brain/awh126.

Davie, CA; Barker, GJ; Thompson, AJ; Tofts, PS; McDonald, WI; Miller, DH; (1997) H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry , 63 (6) 736 - 742.

Davie, CA; Barker, GJ; Thompson, AJ; Tofts, PS; McDonald, WI; Miller, DH; (1997) H-1 magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J NEUROL NEUROSUR PS , 63 (6) 736 - 742.

Davie, CA; Barker, GJ; Webb, S; Tofts, PS; Thompson, AJ; Harding, AE; McDonald, WI; (1996) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss (vol 118, pg 1583, 1995). BRAIN , 119 1415 - 1415. 10.1093/brain/119.4.1415.

Davie, CA; Barker, GJ; Webb, S; Tofts, PS; Thompson, AJ; Harding, AE; McDonald, WI; (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. BRAIN , 118 1583 - 1592.

Davie, CA; Silver, NC; Barker, GJ; Tofts, PS; Thompson, AJ; McDonald, WI; Miller, DW; (1999) Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J NEUROL NEUROSUR PS , 67 (6) 710 - 715.

Davies, GR; Altmann, DR; Hadjiprocopis, A; Rashid, W; Chard, DT; Griffin, CM; Tofts, PS; (2005) Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J NEUROL , 252 (9) 1037 - 1044. 10.1007/s00415-005-0808-x.

Davies, GR; Altmann, DR; Rashid, W; Chard, DT; Griffin, CM; Barker, GJ; Kapoor, R; (2005) Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. MULT SCLER , 11 (3) 276 - 281. 10.1191/1352458505ms1166oa.

Davies, GR; Chard, DT; Griffin, CMB; Rashid, W; Thompson, AJ; Miller, DH; (2002) Triple dose gadolinium enhanced MRI of the brain and spinal cord in early relapsing remitting multiple sclerosis is predictive of future relapses. J NEUROL NEUROSUR PS , 73 (2) 226 - 226.

Davies, GR; Hadjiprocopis, A; Altmann, DR; Chard, DT; Griffin, CM; Rashid, W; Parker, GJ; (2007) Normal-appearing grey and white matter T-1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. MULT SCLER , 13 (2) 169 - 177. 10.1177/1352458506070726.

Davies, GR; Ramani, A; Dalton, CM; Tozer, DJ; Wheeler-Kingshott, CAM; Barker, GJ; Thompson, AJ; (2003) Preliminary magnetic resonance study of the macromolecular proton fraction in white matter: a potential marker of myelin? MULT SCLER , 9 (3) 246 - 249. 10.1191/1352458503ms911oa.

Davies, GR; Ramio-Torrenta, L; Hadjiprocopis, A; Chard, DT; Griffin, CMB; Rashid, W; Barker, GJ; (2004) Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J NEUROL NEUROSUR PS , 75 (7) 998 - 1002. 10.1136/jnnp.2003.021915.

Davies, GR; Tozer, DJ; Cercignani, M; Ramani, A; Dalton, CM; Thompson, AJ; Barker, GJ; (2004) Estimation of the macromolecular proton fraction and bound pool T-2 in multiple sclerosis. MULT SCLER , 10 (6) 607 - 613. 10.1191/1352458504ms1105oa.

De Stefano, N; Giorgio, A; Battaglini, M; Rovaris, M; Sormani, MP; Barkhof, F; Korteweg, T; (2010) Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. NEUROLOGY , 74 (23) 1868 - 1876. 10.1212/WNL.0b013e3181e24136.

Dehmeshki, J; Chard, DT; Leary, SM; Watt, HC; Silver, NC; Tofts, PS; Thompson, AJ; (2003) The normal appearing grey matter in primary progressive multiple sclerosis - A magnetisation transfer imaging study. J NEUROL , 250 (1) 67 - 74. 10.1007/s00415-003-0955-x.

Dehmeshki, J; Silver, NC; Leary, SM; Tofts, PS; Thompson, AJ; Miller, DH; (2001) Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups. J NEUROL SCI , 185 (1) 11 - 17.

Di Filippo, M; Anderson, VM; Altmann, DR; Swanton, JK; Plant, GT; Thompson, AJ; Miller, DH; (2010) Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J NEUROL NEUROSUR PS , 81 (2) 204 - 208. 10.1136/jnnp.2009.171769.

Diane Playford, E; Rossiter, D; Werring, DJ; Thompson, AJ; (1997) Integrated care pathways: Evaluating inpatient rehabilitation in stroke. International Journal of Therapy and Rehabilitation , 4 (2) 97 - 102. 10.12968/bjtr.1997.4.2.14510.

Dobson, R; Miller, RF; Palmer, HE; Feldmann, M; Thompson, EJ; Thompson, AJ; Miller, DH; (2010) Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis. J NEUROIMMUNOL , 220 (1-2) 99 - 103. 10.1016/j.jneuroim.2010.01.012.

Dubois, B; Leary, SM; Nelissen, I; Opdenakker, G; Giovannoni, G; Thompson, AJ; (2003) Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta 1a. J NEUROL , 250 (9) 1037 - 1043. 10.1007/s00415-003-0110-8.

Dubois, B.D.; Keenan, E.; Porter, B.E,; Kapoor, R.; Rudge, P.; Thompson, A.J.; Miller, D.H.; (2003) Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre. Journal of Neurology Neurosurgery & Psychiatry , 74 (7) pp. 946-949. 10.1136/jnnp.74.7.946. Green open access
file

Dubois, BD; Keenan, E; Porter, BE; Kapoor, R; Rudge, P; Thompson, AJ; Miller, DH; (2003) Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre. J NEUROL NEUROSUR PS , 74 (7) 946 - 949.

Edwards, SGM; Playford, ED; Hobart, JC; Thompson, AJ; (2002) Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation. BRIT MED J , 324 (7352) 1493 - 1493. Green open access
file

Edwards, SGM; Thompson, AJ; Losseff, N; Playford, ED; (2002) Shortening inpatient stay for stroke. LANCET , 359 (9324) 2205 - 2205.

Edwards, SGM; Thompson, AJ; Playford, ED; (2004) Integrated care pathways: disease-specific or process-specific? CLIN MED , 4 (2) 132 - 135.

Eshaghi, A; Bodini, B; Ridgway, GR; García-Lorenzo, D; Tozer, D; Sahraian, MA; Thompson, AJ; (2014) Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis. Neuroimage , 86 pp. 257-264. 10.1016/j.neuroimage.2013.09.059. Green open access
file

FEINSTEIN, A; RON, M; THOMPSON, A; (1993) A SERIAL STUDY OF PSYCHOMETRIC AND MAGNETIC-RESONANCE-IMAGING CHANGES IN MULTIPLE-SCLEROSIS. BRAIN , 116 569 - 602.

FILIPPI, M; BARKER, GJ; HORSFIELD, MA; SACARES, PR; MACMANUS, DG; THOMPSON, AJ; TOFTS, PS; (1994) BENIGN AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS - A PRELIMINARY QUANTITATIVE MRI STUDY. J NEUROL , 241 (4) 246 - 251.

FILIPPI, M; PATY, DW; KAPPOS, L; BARKHOF, F; COMPSTON, DAS; THOMPSON, AJ; ZHAO, GJ; (1995) CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRI ACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY. NEUROLOGY , 45 (2) 255 - 260.

FRANCIS, DA; THOMPSON, AJ; BROOKES, P; DAVEY, N; LECHLER, RI; MCDONALD, WI; BATCHELOR, JR; (1991) MULTIPLE-SCLEROSIS AND HLA - IS THE SUSCEPTIBILITY GENE REALLY HLA-DR OR -DQ. HUM IMMUNOL , 32 (2) 119 - 124.

Farrell, R; Kapoor, R; Leary, S; Rudge, P; Thompson, AJ; Millerand, DH; Giovannoni, G; (2008) Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta. MULT SCLER , 14 (2) 212 - 218. 10.1177/1352458507082066.

Fazekas, F; Thompson, A; (2009) New MRI techniques and "aggressive" multiple sclerosis. MULT SCLER , 15 (3) 283 - 284. 10.1177/1352458509102997.

Fernando, KTM; McLean, MA; Chard, DT; MacManus, DG; Dalton, CM; Miszkiel, KA; Gordon, RM; (2004) Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. BRAIN , 127 1361 - 1369. 10.1093/brain/awh153.

Fernando, KTM; Tozer, DJ; Miszkiel, KA; Gordon, RM; Swanton, JK; Dalton, CM; Barker, GJ; (2005) Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. BRAIN , 128 2911 - 2925. 10.1093/brain/awh654.

Filippi, M; Barker, GJ; Sacares, RP; Thompson, A; McDonald, I; Miller, D; (1993) Longstanding lesions and normal appearing white matter in benign and secondary progressive MS: a quantitative MRI study. Schweizer Archiv für Neurologie und Psychiatrie , 114 330 - 331. Gold open access

Filippi, M; Horsfield, MA; Tofts, PS; Barkhof, F; Thompson, AJ; Miller, DH; (1995) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. BRAIN , 118 1601 - 1612.

Filippi, M; Watts, P; Eaton, L; Honer, J; McDonald, WI; Thompson, AJ; (1996) Mark VII Microclimate System (cooling suit) in the symptomatic treatment of multiple sclerosis patients with marked temperature sensitivity. Argomenti di Neurologia , 5 162 - 165.

Fisniku, LK; Altmann, DR; Cercignani, M; Tozer, DJ; Chard, DT; Jackson, JS; Miszkiel, KA; (2009) Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. MULT SCLER , 15 (6) 668 - 677. 10.1177/1352458509103715. Gold open access

Fisniku, LK; Brex, PA; Altmann, DR; Miszkiel, KA; Benton, CE; Lanyon, R; Thompson, AJ; (2008) Disability and T-2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. BRAIN , 131 808 - 817. 10.1093/brain/awm329.

Fisniku, LK; Chard, DT; Jackson, JS; Anderson, VM; Altmann, DR; Miszkiel, KA; Thompson, AJ; (2008) Gray matter atrophy is related to long-term disability in multiple sclerosis. ANN NEUROL , 64 (3) 247 - 254. 10.1002/ana.21423.

Flachenecker, P; Khil, L; Bergmann, S; Kowalewski, M; Pascu, I; Perez-Miralles, F; Sastre-Garriga, J; (2010) Development and pilot phase of a European MS register. J NEUROL , 257 (10) 1620 - 1627. 10.1007/s00415-010-5578-4.

Foong, J; Rozewicz, L; Chong, WK; Thompson, AJ; Miller, DH; Ron, MA; (2000) A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J NEUROL , 247 (2) 97 - 101.

Foong, J; Rozewicz, L; Davie, CA; Thompson, AJ; Miller, DH; Ron, MA; (1999) Correlates of executive function in multiple sclerosis: The use of magnetic resonance spectroscopy as an index of focal pathology. J NEUROPSYCH CLIN N , 11 (1) 45 - 50.

Foong, J; Rozewicz, L; Quaghebeur, G; Davie, CA; Kartsounis, LD; Thompson, AJ; Miller, DH; (1997) Executive function in multiple sclerosis - The role of frontal lobe pathology. BRAIN , 120 15 - 26.

Foong, J; Rozewicz, L; Quaghebeur, G; Thompson, AJ; Miller, DH; Ron, MA; (1998) Neuropsychological deficits in multiple sclerosis after acute relapse. J NEUROL NEUROSUR PS , 64 (4) 529 - 532.

Fox, NC; Jenkins, R; Leary, SM; Stevenson, VL; Losseff, NA; Crum, WR; Harvey, RJ; (2000) Progressive cerebral atrophy in MS - A serial study using registered, volumetric MRI. NEUROLOGY , 54 (4) 807 - 812.

Fox, RJ; Thompson, A; Baker, D; Baneke, P; Brown, D; Browne, P; Chandraratna, D; (2012) Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler , 18 (11) 1534 - 1540. 10.1177/1352458512458169.

Freeman, J; Hobart, JC; Langdon, DW; Thompson, AJ; (2000) Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. J NEUROL NEUROSUR PS , 68 (2) 150 - 156.

Freeman, JA; Hobart, JC; Playford, ED; Undy, B; Thompson, AJ; (2005) Evaluating neurorehabilitation: lessons from routine data collection. J NEUROL NEUROSUR PS , 76 (5) 723 - 728. 10.1136/jnnp.2004.035956.

Freeman, JA; Hobart, JC; Thompson, AJ; (2001) Does adding MS-specific items to a generic measure (the SF-36) improve measurement? NEUROLOGY , 57 (1) 68 - 74.

Freeman, JA; Hobart, JC; Thompson, AJ; (1996) Outcomes-based research in neurorehabilitation: The need for multidisciplinary team involvement. DISABIL REHABIL , 18 (2) 106 - 110.

Freeman, JA; Hobart, JC; Thompson, AJ; (1995) Outcomes-based research in neurorehabilitation: the need for multidisciplinary team involvement. Disability and Rehabilitation , 17 323 - 327.

Freeman, JA; Langdon, DW; Hobart, JC; Thompson, AJ; (1999) Inpatient rehabilitation in multiple sclerosis - Do the benefits carry over into the community? NEUROLOGY , 52 (1) 50 - 56.

Freeman, JA; Langdon, DW; Hobart, JC; Thompson, AJ; (1997) The impact of inpatient rehabilitation on progressive multiple sclerosis. ANN NEUROL , 42 (2) 236 - 244.

Freeman, JA; Langdon, DW; Hobart, JC; Thompson, AJ; (1996) Health-related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation. J NEUROL REHABIL , 10 (3) 185 - 194.

Freeman, JA; Playford, ED; Nicholas, RS; Thompson, AJ; (1996) A neurological rehabilitation unit: Audit of activity and outcome. J ROY COLL PHYS LOND , 30 (1) 21 - 26.

Freeman, JA; Thompson, AJ; (2000) Community services in multiple sclerosis: still a matter of chance. J NEUROL NEUROSUR PS , 69 (6) 728 - 732.

Freeman, JA; Thompson, AJ; (1998) Inpatient rehabilitation in MS. International MS Journal , 5 (1) 16 - 23.

Freeman, JA; Thompson, AJ; Fitzpatrick, R; Hutchinson, M; Miltenburger, C; Beckmann, K; Dahlke, F; (2001) Interferon-beta 1b in the treatment of secondary progressive MS - Impact on quality of life. NEUROLOGY , 57 (10) 1870 - 1875.

Freeman, JA; Thompson, AJ; Freeman, JA; (2001) Building an evidence base for multiple sclerosis management: support for physiotherapy. J NEUROL NEUROSUR PS , 70 (2) 147 - 148.

Freund, P; Curt, A; Friston, K; Thompson, A; (2013) Tracking changes following spinal cord injury: insights from neuroimaging. Neuroscientist , 19 (2) 116 - 128. 10.1177/1073858412449192. Green open access
file

Freund, P; Rothwell, J; Craggs, M; Thompson, AJ; Bestmann, S; (2011) Corticomotor representation to a human forearm muscle changes following cervical spinal cord injury. Eur J Neurosci , 34 (11) 1839 - 1846. 10.1111/j.1460-9568.2011.07895.x.

Freund, P; Schneider, T; Nagy, Z; Hutton, C; Weiskopf, N; Friston, K; Wheeler-Kingshott, CA; (2012) Degeneration of the injured cervical cord is associated with remote changes in corticospinal tract integrity and upper limb impairment. PLOS One , 7 (12) , Article e51729. 10.1371/journal.pone.0051729. Green open access
file

Freund, P; Weiskopf, N; Ashburner, J; Wolf, K; Sutter, R; Altmann, DR; Friston, K; (2013) MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study. Lancet Neurol , 12 (9) pp. 873-881. 10.1016/S1474-4422(13)70146-7. Green open access

Freund, P; Weiskopf, N; Ward, NS; Hutton, C; Gall, A; Ciccarelli, O; Craggs, M; (2011) Disability, atrophy and cortical reorganization following spinal cord injury. Brain , 134 (6) 1610 - 1622. 10.1093/brain/awr093. Green open access
file

Freund, P; Wheeler-Kingshott, C; Jackson, J; Miller, D; Thompson, A; Ciccarelli, O; (2010) Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity. MULT SCLER , 16 (10) 1193 - 1202. 10.1177/1352458510376180.

Freund, P; Wheeler-Kingshott, CA; Nagy, Z; Gorgoraptis, N; Weiskopf, N; Friston, K; Thompson, AJ; (2012) Axonal integrity predicts cortical reorganisation following cervical injury. Journal of Neurology, Neurosurgery & Psychiatry , 83 (6) 629 -637. 10.1136/jnnp-2011-301875. Green open access
file

Freund, PAB; Dalton, C; Wheeler-Kingshott, CAM; Glensman, J; Bradbury, D; Thompson, AJ; Weiskopf, N; (2010) Method for Simultaneous Voxel-Based Morphometry of the Brain and Cervical Spinal Cord Area Measurements Using 3D-MDEFT. J MAGN RESON IMAGING , 32 (5) 1242 - 1247. 10.1002/jmri.22340.

GASS, A; BARKER, GJ; KIDD, D; THORPE, JW; MACMANUS, D; BRENNAN, A; TOFTS, PS; (1994) CORRELATION OF MAGNETIZATION-TRANSFER RATIO WITH CLINICAL DISABILITY IN MULTIPLE-SCLEROSIS. ANN NEUROL , 36 (1) 62 - 67.

Garrard, P; Bradshaw, D; Jager, HR; Thompson, AJ; Losseff, N; Playford, D; (2002) Cognitive dysfunction after isolated brain stem insult. An underdiagnosed cause of long term morbidity. J NEUROL NEUROSUR PS , 73 (2) 191 - 194.

Garrard, P; Farnham, C; Thompson, AJ; Playford, ED; (2004) Rehabilitation of the cancer patient: Experience in a neurological unit. NEUROREHAB NEURAL RE , 18 (2) 76 - 79. 10.1177/0888439004266306.

Garrard, P; Farnham, C; Thompson, AJ; Playford, ED; (2004) Rehabilitation of the cancer patient: experience in a neurological unit. Neurorehabilitation and Neural Repair , 18 (2) pp.76 - 79.

Gasperini, C; Horsfield, MA; Thorpe, JW; Kidd, D; Barker, GJ; Tofts, PS; MacManus, DG; (1996) Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters. J MAGN RESON IMAGING , 6 (4) 580 - 584.

Gasperini, C; Pozzilli, C; Bastianello, S; Koudriavtseva, T; Colleluori, A; Millefiorini, E; Thompson, AJ; (1997) The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: A longitudinal MRI study in relapsing-remitting multiple sclerosis patients. ACTA NEUROL SCAND , 95 (4) 201 - 207.

Gawne-Cain, ML; O'Riordan, JI; Coles, A; Newell, B; Thompson, AJ; Miller, DH; (1998) MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J NEUROL NEUROSUR PS , 64 (2) 197 - 203.

GawneCain, ML; ORiordan, JI; Thompson, AJ; Moseley, IF; Miller, DH; (1997) Multiple sclerosis lesion detect in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo. NEUROLOGY , 49 (2) 364 - 370.

Giovannoni, G; (2003) Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. NEUROLOGY , 61 (7) 1025 - 1025.

Giovannoni, G; Lai, M; Kidd, D; Thorpe, JW; Miller, DH; Thompson, AJ; Keir, G; (1997) Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. BRAIN , 120 1 - 13.

Giovannoni, G; Lai, M; Thorpe, J; Kidd, D; Chamoun, V; Thompson, AJ; Miller, DH; (1997) Longitudinal study of soluble adhesion molecules in multiple sclerosis: Correlation with gadolinium enhanced magnetic resonance Imaging. NEUROLOGY , 48 (6) 1557 - 1565.

Giovannoni, G; Miller, DH; Losseff, NA; Sailer, M; Lewellyn-Smith, N; Thompson, AJ; Thompson, EJ; (2001) Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J NEUROL , 248 (6) 487 - 495.

Giovannoni, G; Thompson, AJ; Miller, DH; Thompson, EJ; (2001) Fatigue is not associated with raised inflammatory markers in multiple sclerosis. NEUROLOGY , 57 (4) 676 - 681.

Giovannoni, G; Thorpe, JW; Kidd, D; Kendall, BE; Moseley, IF; Thompson, AJ; Keir, G; (1996) Soluble E-selectin in multiple sclerosis: Raised concentrations in patients with primary progressive disease. J NEUROL NEUROSUR PS , 60 (1) 20 - 26.

Gorgoraptis, N; Wheeler-Kingshott, CAM; Jenkins, TM; Altmann, DR; Miller, DH; Thompson, AJ; Ciccarelli, O; (2010) Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. MULT SCLER , 16 (5) 555 - 565. 10.1177/1352458510362440.

Griffin, CM; Chard, DT; Ciccarelli, O; Kapoor, R; Barker, GJ; Thompson, AJ; Miller, DH; (2001) Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. MULT SCLER , 7 (5) 290 - 297.

Griffin, CM; Chard, DT; Parker, GJM; Barker, GJ; Thompson, AJ; Miller, DH; (2002) The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J NEUROL , 249 (2) 193 - 199.

Griffin, CM; Dehmeshki, J; Chard, DT; Parker, GJM; Barker, GJ; Thompson, AJ; Miller, DH; (2002) T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis. MULT SCLER , 8 (3) 211 - 216. 10.1191/1352458502ms807oa.

Griffin, CM; Parker, GJM; Barker, GJ; Tompson, AJ; Miller, DH; (2000) MTR and TI provide complementary information in MS NAWM, but not in lesions. MULT SCLER , 6 (5) 327 - 331.

Grimaud, J; Barker, GJ; Wang, L; Lai, M; MacManus, DG; Webb, SL; Thompson, AJ; (1999) Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study. J NEUROL , 246 (10) 961 - 967.

Hardy, J; Thompson, AJ; (2011) Dissecting the Familial Risk of Multiple Sclerosis. ANN NEUROL , 69 (1) 11 - 12. 10.1002/ana.22353.

Hatch, J; Johnson, J; Thompson, A; (1998) Standards of health care for people with multiple sclerosis. MS Management , 5 (1) 16 - 23.

Hickman, SJ; Coulon, O; Parker, GJM; Barker, GJ; Stevenson, VL; Chard, DT; Arridge, SR; (2003) Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images. JOURNAL OF MAGNETIC RESONANCE IMAGING , 18 (3) 368 - 371. 10.1002/jmri.10354.

Hickman, SJ; Toosy, AT; Jones, SJ; Altmann, DR; Miszkiel, KA; MacManus, DG; Barker, GJ; (2004) A serial MRI study following optic nerve mean area in acute optic neuritis. BRAIN , 127 2498 - 2505. 10.1093/brain/awh284.

Hickman, SJ; Toosy, AT; Jones, SJ; Altmann, DR; Miszkiel, KA; MacManus, DG; Barker, GJ; (2004) Serial magnetization transfer imaging in acute optic neuritis. BRAIN , 127 692 - 700. 10.1093/brain/awh076.

Hickman, SJ; Toosy, AT; Miszkiel, KA; Jones, SJ; Altmann, DR; MacManus, DG; Plant, GT; (2004) Visual recovery following acute optic neuritis - A clinical, electrophysiological and magnetic resonance imaging study. J NEUROL , 251 (8) 996 - 1005. 10.1007/s00415-004-0477-1.

Hobart, J; Cano, S; Baron, R; Thompson, A; Schwid, S; Zajicek, J; Andrich, D; (2013) Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis. Mult Scler , 19 (13) 1773 - 1783. 10.1177/1352458513483378.

Hobart, J; Freeman, J; Lamping, D; Fitzpatrick, R; Thompson, A; (2001) The SF-36 in multiple sclerosis: why basic assumptions must be tested. J NEUROL NEUROSUR PS , 71 (3) 363 - 370.

Hobart, J; Freeman, J; Thompson, A; (2000) Kurtzke scales revisited: the application of psychometric methods to clinical intuition. BRAIN , 123 1027 - 1040.

Hobart, J; Kalkers, N; Barkhof, F; Uitdehaag, B; Polman, C; Thompson, A; (2004) Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. MULT SCLER , 10 (1) 41 - 46. 10.1191/1352458504ms983oa.

Hobart, J; Lamping, D; Fitzpatrick, R; Riazi, A; Thompson, A; (2001) The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient-based outcome measure. BRAIN , 124 962 - 973.

Hobart, J; Riazi, A; Lamping, D; Fitzpatrick, R; Thompson, AJ; (2002) Evaluating the use of B-INTERFERON in the UK: From whose perspective? J NEUROL NEUROSUR PS , 73 (2) 227 - 227.

Hobart, J; Thompson, A; (1997) A comparison of two neurologic scoring instruments for multiple sclerosis. J NEUROL , 244 (1) 60 - 60.

Hobart, J.; Lamping, D.; Fitzpatrick, R.; Riazi, A.; Thompson, A.; (2001) The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain , 124 (5) pp. 962-973. 10.1093/brain/124.5.962.

Hobart, J.C.; Lamping, D.L.; Freeman, J.A.; Langdon, D.W.; McLellan, D.L.; Greenwood, R.J.; Thompson, A.J.; (2001) Evidence-based measurement: which disability scale for neurologic rehabilitation? Neurology , 57 (4) pp. 639-644.

Hobart, JC; Cano, SJ; Thompson, AJ; (2010) Effect sizes can be misleading: is it time to change the way we measure change? J NEUROL NEUROSUR PS , 81 (9) 1044 - 1048. 10.1136/jnnp.2009.201392.

Hobart, JC; Cano, SJ; Warner, TT; Thompson, AJ; (2012) What sample sizes for reliability and validity studies in neurology? J Neurol , 259 (12) 2681 - 2694. 10.1007/s00415-012-6570-y.

Hobart, JC; Cano, SJ; Zajicek, JP; Thompson, AJ; (2008) Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations (vol 6, pg 1094, 2007). LANCET NEUROLOGY , 7 (1) 25 - 25.

Hobart, JC; Cano, SJ; Zajicek, JP; Thompson, AJ; (2007) Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. LANCET NEUROL , 6 (12) 1094 - 1105.

Hobart, JC; Lamping, DL; Freeman, JA; Langdon, DW; McLellan, DL; Greenwood, RJ; Thompson, AJ; (2001) Evidence-based measurement - Which disability scale for neurologic rehabilitation? NEUROLOGY , 57 (4) 639 - 644.

Hobart, JC; Lamping, DL; Thompson, AJ; (1996) Evaluating neurological outcome measures: The bare essentials. J NEUROL NEUROSUR PS , 60 (2) 127 - 130.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2005) How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. J NEUROL NEUROSUR PS , 76 (11) 1539 - 1543. 10.1136/jnnp.2005.064584.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2004) Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. HEALTH TECHNOL ASSES , 8 (9) 1 - +.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2004) Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess , 8 (9) iii - 48.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2003) Measuring the impact of MS on walking ability - The 12-Item MS Walking Scale (MSWS-12). NEUROLOGY , 60 (1) 31 - 36.

Hobart, JC; Riazi, A; Thompson, AJ; Styles, IM; Ingram, W; Vickery, PJ; Warner, M; (2006) Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). BRAIN , 129 224 - 234. 10.1093/brain/awh675.

Hobart, JC; Thompson, AJ; (2001) The five item Barthel index. J NEUROL NEUROSUR PS , 71 (2) 225 - 230.

Hobart, JC; Williams, LS; Moran, K; Thompson, AJ; (2002) Quality of life measurement after stroke - Uses and abuses of the SF-36. STROKE , 33 (5) 1348 - 1356. 10.1161/01.STR.0000015030.59594.B3.

Holland, A; O'Connor, RJ; Thompson, AJ; Playford, ED; Hobart, JC; (2006) Talking the talk on walking the walk - A 12-item generic walking scale suitable for neurological conditions? J NEUROL , 253 (12) 1594 - 1602. 10.1007/s00415-006-0272-2.

Horsfield, MA; Barker, GJ; Barkhof, F; Miller, DH; Thompson, AJ; Filippi, M; (2003) Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J MAGN RESON IMAGING , 17 (4) 389 - 397. 10.1002/jmri.10266.

Hunter, RM; Davie, C; Rudd, A; Thompson, A; Walker, H; Thomson, N; Mountford, J; (2013) Impact on Clinical and Cost Outcomes of a Centralized Approach to Acute Stroke Care in London: A Comparative Effectiveness Before and After Model. PLoS One , 8 (8) , Article e70420. 10.1371/journal.pone.0070420. Green open access
file

Ingle, GT; Sastre-Garriga, J; Miller, DH; Thompson, AJ; (2005) Is inflammation important in early PPMS? a longitudinal MRI study. J NEUROL NEUROSUR PS , 76 (9) 1255 - 1258. 10.1136/jnnp.2004.036590. Gold open access

Ingle, GT; Stevenson, VL; Leary, SM; Miller, DH; Thompson, AJ; (2002) A 5 year longitudinal MRI study of ventricular volume in primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 73 (2) 217 - 217.

Ingle, GT; Stevenson, VL; Miller, DH; Leary, SM; Rovaris, M; Barkhof, F; Brochet, B; (2002) Two-year follow-up study of primary and transitional progressive multiple sclerosis. MULT SCLER , 8 (2) 108 - 114. 10.1191/1352458502ms778oa.

Ingle, GT; Stevenson, VL; Miller, DH; Thompson, AJ; (2003) Primary progressive multiple sclerosis: a 5-year clinical and MR study. BRAIN , 126 2528 - 2536. 10.1093/brain/awg261.

Ingle, GT; Thompson, AJ; Miller, DH; (2002) Magnetic resonance imaging in primary progressive multiple sclerosis. J REHABIL RES DEV , 39 (2) 261 - 271. Gold open access

Inglese, M; van Waesberghe, JHTM; Rovaris, M; Beckmann, K; Barkhof, F; Hahn, D; Kappos, L; (2003) The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. NEUROLOGY , 60 (5) 853 - 860.

Ingram, DA; Thompson, AJ; Swash, M; (1988) Central motor conduction in multiple sclerosis: evaluation of abnormalities revealed by transcutaneous magnetic stimulation of the brain. J Neurol Neurosurg Psychiatry , 51 (4) 487 - 494.

Ingram, DAM; Thompson, AJ; Swash, M; (1988) Central motor conduction in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry , 51 487 - 494.

Isaacs, JD; Bodini, B; Ciccarelli, O; Scadding, GK; Thompson, AJ; (2011) Atopic myelitis in a European woman residing in Japan. J NEUROL NEUROSUR PS , 82 (9) 1022 - 1024. 10.1136/jnnp.2009.186775.

JONES, SJ; TURANO, G; KRISS, A; SHAWKAT, F; KENDALL, B; THOMPSON, AJ; (1995) VISUAL-EVOKED POTENTIALS IN PHENYLKETONURIA - ASSOCIATION WITH BRAIN MRI, DIETARY STATE, AND IQ. J NEUROL NEUROSUR PS , 59 (3) 260 - 265.

Jarrett, L; Leary, SM; Porter, B; Richardson, D; Rosso, T; Powell, M; Thompson, AJ; (2001) Managing spasticity in people with multiple sclerosis: a goal-oriented approach to intrathecal baclofen therapy. International Journal of MS Care , 3 (4)

Jarrett, L; Nandi, P; Thompson, AJ; (2002) Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role? J NEUROL NEUROSUR PS , 73 (6) 705 - 709.

Jenkins, T; Ciccarelli, O; Toosy, A; Miszkiel, K; Wheeler-Kingshott, C; Altmann, D; Mancini, L; (2010) Dissecting Structure-Function Interactions in Acute Optic Neuritis to Investigate Neuroplasticity. HUM BRAIN MAPP , 31 (2) 276 - 286. 10.1002/hbm.20863.

Jenkins, T; Toosy, AT; Ciccarelli, O; Miszkiel, KA; Wheeler-Kingshott, CA; Henderson, AP; Kallis, C; (2010) Reply. Annals of Neurology , 68 (6) 971 - 971. 10.1002/ana.22030.

Jenkins, T; Toosy, AT; Ciccarelli, O; Miszkiel, KA; Wheeler-Kingsnott, CA; Henderson, AP; Kallis, C; (2010) Neuroplasticity Predicts Outcome of Optic Neuritis Independent of Tissue Damage Reply. ANN NEUROL , 68 (6) 971 - 971. 10.1002/ana.22030.

Jenkins, TM; Ciccarelli, O; Atzori, M; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; Toosy, AT; (2011) Early pericalcarine atrophy in acute optic neuritis is associated with conversion to multiple sclerosis. J NEUROL NEUROSUR PS , 82 (9) 1017 - 1021. 10.1136/jnnp.2010.239715.

Jenkins, TM; Khaleeli, Z; Thompson, AJ; (2008) Diagnosis and management of primary progressive multiple sclerosis. Minerva Med , 99 (2) 141 - 155.

Jenkins, TM; Thompson, AJ; (2009) Diagnosing and managing multiple sclerosis. Practitioner , 253 (1721) 25 - 3.

Jenkins, TM; Thompson, AJ; (2007) GPs have pivotal role in managing MS. Practitioner , 251 (1694) 37 - passim.

Jenkins, TM; Toosy, AT; Ciccarelli, O; Miszkiel, KA; Wheeler-Kingshott, CA; Henderson, AP; Kallis, C; (2010) Neuroplasticity Predicts Outcome of Optic Neuritis Independent of Tissue Damage. ANN NEUROL , 67 (1) 99 - 113. 10.1002/ana.21823.

Johansen-Berg, H; Behrens, TEJ; Sillery, E; Ciccarelli, O; Thompson, AJ; Smith, SM; Matthews, PM; (2005) Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. CEREB CORTEX , 15 (1) 31 - 39. 10.1093/cercor/bhh105.

Johansen-Berg, H.; Behrens, T.E.J.; Ciccarelli, O.; Thompson, A.J.; Smith, S.M.; Matthews, P.M.; Sillery, E.; (2005) Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cerebral Cortex , 15 (1) pp. 31-39. 10.1093/cercor/bhh105.

Johnson, J; Thompson, A; (1996) Rehabilitation in a neuroscience centre: the role of expert assessment and selection. British Journal of Therapy and Rehabilitation , 3 303 - 308.

Jones, SJ; Turano, G; Kriss, A; Shawkat, F; Kellar-Wood, HF; Thompson, AJ; (1995) Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and intelligence quotient. Journal of Neurology, Neurosurgery and Psychiatry , 59 260 - 265.

KERMODE, AG; RUDGE, P; THOMPSON, AJ; DUBOULAY, EPGH; MCDONALD, WI; (1990) MRI OF THORACIC CORD IN TROPICAL SPASTIC PARAPARESIS. J NEUROL NEUROSUR PS , 53 (12) 1110 - 1111.

KERMODE, AG; RUDGE, P; THOMPSON, AJ; DUBOULAY, EPGH; MCDONALD, WI; (1990) MRI OF THORACIC CORD IN TROPICAL SPASTIC PARAPARESIS. J NEUROL NEUROSUR PS , 53 (8) 710 - 710.

KERMODE, AG; THOMPSON, AJ; TOFTS, P; MACMANUS, DG; KENDALL, BE; KINGSLEY, DPE; MOSELEY, IF; (1990) BREAKDOWN OF THE BLOOD-BRAIN-BARRIER PRECEDES SYMPTOMS AND OTHER MRI SIGNS OF NEW LESIONS IN MULTIPLE-SCLEROSIS - PATHOGENETIC AND CLINICAL IMPLICATIONS. BRAIN , 113 1477 - 1489.

KERMODE, AG; TOFTS, PS; THOMPSON, AJ; MACMANUS, DG; RUDGE, P; KENDALL, BE; KINGSLEY, DPE; (1990) HETEROGENEITY OF BLOOD-BRAIN-BARRIER CHANGES IN MULTIPLE-SCLEROSIS - AN MRI STUDY WITH GADOLINIUM-DTPA ENHANCEMENT. NEUROLOGY , 40 (2) 229 - 235.

KIDD, D; STEWART, G; BALDRY, J; JOHNSON, J; ROSSITER, D; PETRUCKEVITCH, A; THOMPSON, AJ; (1995) THE FUNCTIONAL INDEPENDENCE MEASURE - A COMPARATIVE VALIDITY AND RELIABILITY STUDY. DISABIL REHABIL , 17 (1) 10 - 14.

KIDD, D; THOMPSON, AJ; KENDALL, BE; MILLER, DH; MCDONALD, WI; (1994) BENIGN FORM OF MULTIPLE-SCLEROSIS - MRI EVIDENCE FOR LESS FREQUENT AND LESS INFLAMMATORY DISEASE-ACTIVITY. J NEUROL NEUROSUR PS , 57 (9) 1070 - 1072.

KIDD, D; THORPE, JW; THOMPSON, AJ; KENDALL, BE; MOSELEY, IF; MACMANUS, DG; MCDONALD, WI; (1993) SPINAL-CORD MRI USING MULTIARRAY COILS AND FAST SPIN-ECHO .2. FINDINGS IN MULTIPLE-SCLEROSIS. NEUROLOGY , 43 (12) 2632 - 2637.

Kachramanoglou, C; De Vita, E; Thomas, DL; Wheeler-Kingshott, CA; Balteau, E; Carlstedt, T; Choi, D; (2013) Metabolic changes in the spinal cord after brachial plexus root re-implantation. Neurorehabil Neural Repair , 27 (2) 118 - 124. 10.1177/1545968312457825. Green open access
file

Kachramanoglou, C; De Vita, E; Thomas, DL; Wheeler-Kingshott, CAM; Balteau, E; Carlstedt, T; Choi, D; (2013) Metabolic Changes in the Spinal Cord After Brachial Plexus Root Re-implantation. NEUROREHABILITATION AND NEURAL REPAIR , 27 (2) 118 - 124. 10.1177/1545968312457825.

Kapeller, P; Brex, PA; Chard, D; Dalton, C; Griffin, CM; McLean, MA; Parker, GJM; (2002) Quantitative H-1 MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. MULT SCLER , 8 (3) 207 - 210. 10.1191/1352458502ms822oa.

Kapeller, P; McLean, MA; Griffin, CM; Chard, D; Parker, GJM; Barker, GJ; Thompson, AJ; (2001) Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J NEUROL , 248 (2) 131 - 138.

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Beckmann, K; Dahlke, F; European Study Grp Beta-1b Seconda, ; (2001) Final analysis of the European multicenter trial on IFN beta-1b in secondary-progressive MS. NEUROLOGY , 57 (11) 1969 - 1975.

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight, R; Hern, J; (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. LANCET , 352 (9139) 1491 - 1497.

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight, R; Hern, J; (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. The Lancet , 352 (9139) 1491 - 1497.

Kappos, L; Polman, C; Thompson, AJ; Duda, P; Clanet, M; Comi, G; Hartung, HP; (2003) Towards a European Network for Multiple Sclerosis Trials (ENMST). MULT SCLER , 9 (6) 627 - 629. 10.1191/1352458503ms962xx.

Kappos, L; Weinshenker, B; Pozzilli, C; Thompson, AJ; Dahlke, F; Beckmann, K; Polman, C; (2004) Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology , 63 (10) 1779 - 1787.

Karrenbauer, VD; Leoni, V; Lim, ET; Giovannoni, G; Ingle, GT; Sastre-Garriga, J; Thompson, AJ; (2006) Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. CLIN NEUROL NEUROSUR , 108 (5) 456 - 460. 10.1016/j.clineuro.2005.07.010.

Kerrison, S; Laws, S; Cane, M; Thompson, A; (2008) The patient's experience of being a human subject. J ROY SOC MED , 101 (8) 416 - 422. 10.1258/jrsm.2007.070288.

Kersten, P; McLellan, DL; Gross-Paju, K; Grigoriadis, N; Bencivenga, R; Beneton, C; Charlier, M; (2000) A questionnaire assessment of unmet needs for rehabilitation services and resources for people with multiple sclerosis: results of a pilot survey in five European countries. CLIN REHABIL , 14 (1) 42 - 49.

Kesselring, J; Coenen, M; Cieza, A; Thompson, A; Kostanjsek, N; Stucki, G; (2008) Developing the ICF Core Sets for multiple sclerosis to specify functioning. MULT SCLER , 14 (2) 252 - 254. 10.1177/1352458507082615.

Kesselring, J; Thompson, AJ; (1997) Spasticity, ataxia and fatigue in multiple sclerosis. BAILLIERE CLIN NEUR , 6 (3) 429 - 445.

Khaleeli, Z; Altmann, DR; Cercignani, M; Ciccarelli, O; Miller, DH; Thompson, AJ; (2008) Magnetization Transfer Ratio in Gray Matter A Potential Surrogate Marker for Progression in Early Primary Progressive Multiple Sclerosis. ARCH NEUROL-CHICAGO , 65 (11) 1454 - 1459.

Khaleeli, Z; Cereignani, M; Audoin, B; Ciccarelli, O; Miller, DH; Thompson, AJ; (2007) Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. NEUROIMAGE , 37 (1) 253 - 261. 10.1016/j.neuroimage.2007.04.056.

Khaleeli, Z; Ciccarelli, O; Manfredonia, F; Barkhof, F; Brochet, B; Cercignani, M; Dousset, V; (2008) Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study. ANN NEUROL , 63 (6) 790 - 793. 10.1002/ana.21375.

Khaleeli, Z; Ciccarelli, O; Mizskiel, K; Altmann, D; Miller, DH; Thompson, AJ; (2010) Lesion enhancement diminishes with time in primary progressive multiple sclerosis. MULT SCLER , 16 (3) 317 - 324. 10.1177/1352458509358090.

Khaleeli, Z; Sastre-Garriga, J; Ciccarelli, O; Miller, DH; Thompson, AJ; (2007) Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 78 (10) 1076 - 1082. 10.1136/jnnp.2006.107565. Gold open access

Kidd, D; Barker, GJ; Tofts, PS; Gass, A; Thompson, AJ; McDonald, WI; Miller, DH; (1997) The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis. J NEUROL , 244 (2) 125 - 130.

Kidd, D; Howard, RS; Losseff, NA; Thompson, AJ; (1995) The benefit of inpatient neurorehabilitation in multiple sclerosis. Clinical Rehabilitation , 9 (3) 198 - 203.

Kidd, D; Thompson, AJ; (1997) Prospective study of neurorehabilitation in multiple sclerosis. J NEUROL NEUROSUR PS , 62 (4) 423 - 424.

Kidd, D; Thompson, AJ; MacManus, DG; Kendall, BE; McDonald, WI; (1993) Benign MS:MRI evidence for a less inflammatory disease. Journal of Neurology, Neurosurgery and Psychiatry , 56 730 - ?.

Kidd, D; Thompson, PD; Day, BL; Rothwell, JC; Kendall, BE; Thompson, AJ; Marsden, CD; (1998) Central motor conduction time in progressive multiple sclerosis - Correlations with MRI and disease activity. BRAIN , 121 1109 - 1116.

Kidd, D; Thorpe, JW; Kendall, BE; Barker, GJ; Miller, DH; McDonald, WI; Thompson, AJ; (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J NEUROL NEUROSUR PS , 60 (1) 15 - 19.

Kolappan, M; Henderson, APD; Jenkins, TM; Wheeler-Kingshott, CAM; Plant, GT; Thompson, AJ; Miller, DH; (2009) Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J NEUROL , 256 (3) 305 - 319. 10.1007/s00415-009-0123-z.

Koudriavtseva, T; Thompson, AJ; Fiorelli, M; Gasperini, C; Bastianello, S; Bozzao, A; Paolillo, A; (1997) Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry , 62 (3) 285 - 287.

Kragt, JJ; Thompson, AJ; Montalban, X; Tintore, M; Rio, J; Polman, CH; Uitdehaag, BMJ; (2008) Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. NEUROLOGY , 70 (13) 1084 - 1091.

Kristoferitsch, W; Seeldrayers, P; Kyriallis, K; Brochet, B; Confavreux, C; Clanet, M; Cesaro, P; (2001) Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data. MULTIPLE SCLEROSIS , 7 (3) 179 - 183.

Lai, HM; Davie, CA; Gass, A; Barker, GJ; Webb, S; Tofts, PS; Thompson, AJ; (1997) Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J NEUROL , 244 (5) 308 - 311.

Lai, M; Hodgson, T; GawneCain, M; Webb, S; MacManus, D; McDonald, WI; Thompson, AJ; (1996) A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J NEUROL NEUROSUR PS , 60 (3) 339 - 341.

Langdon, DW; Thompson, AJ; (2000) Relation of impairment to everyday competence in visual disorientation syndrome: Evidence from a single case study. ARCH PHYS MED REHAB , 81 (5) 686 - 691.

Langdon, DW; Thompson, AJ; (1999) Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. MULT SCLER , 5 (2) 94 - 100.

Langdon, DW; Thompson, AJ; (1996) Cognitive problems in multiple sclerosis. MS Management , 3 1 - 9.

Lazeron, RHC; Langdon, DW; Filippi, M; van Waesberghe, JHTM; Stevenson, VL; Boringa, JBS; Origgi, D; (2000) Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR. MULT SCLER , 6 (4) 280 - 285.

Leary, SM; Brex, PA; MacManus, DG; Parker, GJM; Barker, GJ; Miller, DH; Thompson, AJ; (2000) A H-1 magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. MAGN RESON IMAGING , 18 (4) 455 - 459.

Leary, SM; Davie, CA; Parker, GJM; Stevenson, VL; Wang, LQ; Barker, GJ; Miller, DH; (1999) H-1 Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J NEUROL , 246 (11) 1023 - 1026.

Leary, SM; Miller, DH; Stevenson, VL; Brex, PA; Chard, DT; Thompson, AJ; (2003) Interferon beta-1a in primary progressive MS - An exploratory, randomized, controlled trial. NEUROLOGY , 60 (1) 44 - 51.

Leary, SM; Parker, GJM; Stevenson, VL; Barker, GJ; Miller, DH; Thompson, AJ; (1999) Reproducibility of magnetic resonance imaging measurements of spinal cord atrophy: The role of quality assurance. MAGN RESON IMAGING , 17 (5) 773 - 776.

Leary, SM; Porter, B; Thompson, AJ; (2005) Multiple sclerosis: diagnosis and the management of acute relapses. POSTGRAD MED J , 81 (955) 302 - 308. 10.1136/pgmj.2004.029413.

Leary, SM; Silver, NC; Stevenson, VL; Barker, GJ; Miller, DH; Thompson, AJ; (1999) Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis. MULT SCLER , 5 (5) 313 - 316.

Leary, SM; Stevenson, VL; Miller, DH; Thompson, AJ; (1999) Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis. J NEUROL , 246 (7) 562 - 568.

Leary, SM; Thompson, AJ; (2005) Primary progressive multiple sclerosis - Current and future treatment options. CNS DRUGS , 19 (5) 369 - 376.

Leary, SM; Thompson, AJ; (2004) The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 75 (3) 508 - 509.

Leary, SM; Thompson, AJ; (2003) Interferon beta-1a in primary progressive multiple sclerosis. J NEUROL SCI , 206 (2) 215 - 216.

Leary, SM; Thompson, AJ; (2000) Current management of multiple sclerosis. INT J CLIN PRACT , 54 (3) 161 - 169.

Leslie, TA; Goldsmith, PC; Thompson, AJ; Dowd, PM; (1993) Degos disease and spastic paraplegia. Clin Exp Dermatol , 18 (4) 344 - 346.

Lim, ET; Petzold, A; Leary, SM; Altmann, DR; Keir, G; Thompson, EJ; Miller, DH; (2004) Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a. J Negat Results Biomed , 3 4 - ?. 10.1186/1477-5751-3-4.

Liu, C; Playford, ED; Thompson, AJ; (2003) Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J NEUROL , 250 (10) 1214 - 1218. 10.1007/s00415-003-0187-0.

Liu, C; Thompson, AJ; Playford, ED; (2004) Patient dissatisfaction: Insights into the rehabilitation process. J NEUROL , 251 (9) 1094 - 1097. 10.1007/s00415-004-0488-y.

LlewellynSmith, N; Lai, M; Miller, DH; Rudge, P; Thompson, AJ; Cuzner, ML; (1997) Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production - A study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412. NEUROLOGY , 48 (4) 810 - 816.

Losseff, NA; Kingsley, DP; McDonald, WI; Miller, DH; Thompson, AJ; (1996) Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler , 1 (4) 218 - 222.

Losseff, NA; Miller, DH; Kidd, D; Thompson, AJ; (2001) The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis - preliminary results. MULT SCLER , 7 (1) 23 - 25.

Losseff, NA; Thompson, AJ; (1995) The medical management of increased tone. Physiotherapy , 81 480 - 484.

Losseff, NA; Wang, L; Lai, HM; Yoo, DS; GawneCain, ML; McDonald, WI; Miller, DH; (1996) Progressive cerebral atrophy in multiple sclerosis - A serial MRI study. BRAIN , 119 2009 - 2019.

Losseff, NA; Wang, L; Miller, DH; Thompson, AJ; (2001) T1 hypointensity of the spinal cord in multiple sclerosis. J NEUROL , 248 (6) 517 - 521.

Losseff, NA; Webb, SL; ORiordan, JI; Page, R; Wang, L; Barker, GJ; Tofts, PS; (1996) Spinal cord atrophy and disability in multiple sclerosis - A new reproducible and sensitive MRI method with potential to monitor disease progression. BRAIN , 119 701 - 708.

Lublin, FD; Reingold, SC; Cohen, JA; Cutter, GR; Sørensen, PS; Thompson, AJ; Wolinsky, JS; (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology , 83 (3) 278 - 286. 10.1212/WNL.0000000000000560.

Lycklama, G; Thompson, A; Filippi, M; Miller, D; Polman, C; Fazekas, F; Barkhof, F; (2003) Spinal-cord MRI in multiple sclerosis. Lancet Neurol , 2 (9) 555 - 562.

MANJI, H; CONNOLLY, S; MCALLISTER, R; VALENTINE, AR; KENDALL, BE; FELL, M; DURRANCE, P; (1994) SERIAL MRI OF THE BRAIN IN ASYMPTOMATIC PATIENTS INFECTED WITH HIV - RESULTS FROM THE UCMSM/MEDICAL RESEARCH COUNCIL NEUROLOGY COHORT. J NEUROL NEUROSUR PS , 57 (2) 144 - 149.

MARTIN, EA; LAVIN, PJ; THOMPSON, AJ; (1984) PAINFUL EXTREMITIES AND NEUROLOGICAL DISORDER IN ESSENTIAL THROMBOCYTHEMIA. J ROY SOC MED , 77 (5) 372 - 374.

MCDONALD, WI; MILLER, DH; THOMPSON, AJ; (1994) ARE MAGNETIC-RESONANCE FINDINGS PREDICTIVE OF CLINICAL OUTCOME IN THERAPEUTIC TRIALS IN MULTIPLE-SCLEROSIS - THE DILEMMA OF INTERFERON-BETA. ANN NEUROL , 36 (1) 14 - 18.

MILLER, D; BARKHOF, F; BERRY, I; KAPPOS, L; SCOTTI, G; THOMPSON, A; (1992) MRI IN MONITORING THE TREATMENT OF MULTIPLE-SCLEROSIS - CONCERTED ACTION GUIDELINES - REPLY. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 55 (10) 978 - 978. 10.1136/jnnp.55.10.978-a.

MILLER, DH; BARKHOF, F; BERRY, I; KAPPOS, L; SCOTTI, G; THOMPSON, AJ; (1991) MAGNETIC-RESONANCE-IMAGING IN MONITORING THE TREATMENT OF MULTIPLE-SCLEROSIS - CONCERTED ACTION GUIDELINES. J NEUROL NEUROSUR PS , 54 (8) 683 - 688.

MILLER, DH; THOMPSON, AJ; MORRISSEY, SP; MACMANUS, DG; MOORE, SG; KENDALL, BE; MOSELEY, IF; (1992) HIGH-DOSE STEROIDS IN ACUTE RELAPSES OF MULTIPLE-SCLEROSIS - MRI EVIDENCE FOR A POSSIBLE MECHANISM OF THERAPEUTIC EFFECT. J NEUROL NEUROSUR PS , 55 (6) 450 - 453.

Mancini, L; Ciccarelli, O; Manfredonia, F; Thornton, JS; Agosta, F; Barkhof, F; Beckmann, C; (2009) Short-term adaptation to a simple motor task: A physiological process preserved in multiple sclerosis. NEUROIMAGE , 45 (2) 500 - 511. 10.1016/j.neuroimage.2008.12.006.

Manfredonia, F; Ciccarelli, O; Khaleeli, Z; Tozer, DJ; Sastre-Garriga, J; Miller, DH; Thompson, AJ; (2007) Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. ARCH NEUROL-CHICAGO , 64 (3) 411 - 415.

Manji, H; Connolly, S; McAllister, RH; Valentine, AR; Kendall, BE; Fell, M; Durrance, P; (1994) Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort. Journal of Neurology, Neurosurgery and Psychiatry , 57 144 - 149.

Mann, CLA; Davies, MB; Stevenson, VL; Leary, SM; Boggild, MD; Ko, CK; Jones, PW; (2002) Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J NEUROIMMUNOL , 129 (1-2) 197 - 204.

Manson, SC; Wegner, C; Filippi, M; Barkhof, F; Beckmann, C; Ciccarelli, O; De Stefano, N; (2008) Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. EXP BRAIN RES , 187 (1) 25 - 31. 10.1007/s00221-008-1276-1.

Marsden, J; Ramdharry, G; Stevenson, V; Thompson, A; (2012) Muscle paresis and passive stiffness: key determinants in limiting function in Hereditary and Sporadic Spastic Paraparesis. Gait & Posture , 35 (2) 266 - 271. 10.1016/j.gaitpost.2011.09.018. Green open access
file

Martino, G; Franklin, RJ; Baron Van Evercooren, A; Kerr, DA; Stem Cells in Multiple Sclerosis (STEMS) Consensus Group, ; (2010) Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol , 6 (5) 247 - 255. 10.1038/nrneurol.2010.35.

McCrone, P; Heslin, M; Knapp, M; Bull, P; Thompson, A; (2008) Multiple Sclerosis in the UK Service Use, Costs, Quality of Life and Disability. PHARMACOECONOMICS , 26 (10) 847 - 860.

McDonald, WI; Compston, A; Edan, G; Goodkin, D; Hartung, HP; Lublin, FD; McFarland, HF; (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. ANN NEUROL , 50 (1) 121 - 127.

McDonald, WI; Fazekas, F; Thompson, AJ; (2003) [Diagnosis of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (Spec No 2) 4 - 9.

Miller, D; Barkhof, F; Montalban, X; Thompson, A; Filippi, M; (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. LANCET NEUROLOGY , 4 (6) 341 - 348.

Miller, D; Barkhof, F; Montalban, X; Thompson, A; Filippi, M; (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part 1: natural history, pathogenesis, diagnosis, and prognosis. LANCET NEUROLOGY , 4 (5) 281 - 288.

Miller, DH; Barkhof, F; Frank, JA; Parker, GJM; Thompson, AJ; (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. BRAIN , 125 1676 - 1695.

Miller, DH; Leary, SM; Thompson, AJ; (2004) Overview of London trial of intramuscular interferon-beta 1a in primary-progressive multiple sclerosis. MULTIPLE SCLEROSIS , 10 S56 - S57. 10.1191/1352458504ms1031oa.

Miller, DH; Thompson, AJ; (1999) Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis. PHILOS T R SOC B , 354 (1390) 1687 - 1695.

Miller, DH; Thompson, AJ; Filippi, M; (2003) Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. JOURNAL OF NEUROLOGY , 250 (12) 1407 - 1419. 10.1007/s00415-003-0243-9.

Miller, DH; Thompson, AJ; Kappos, L; (2001) MRI and assessment of treatment in multiple sclerosis. BRAIN , 124 1052 - 1053.

Molyneux, PD; Barker, GJ; Barkhof, F; Beckmann, K; Dahlke, F; Filippi, M; Ghazi, M; (2001) Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS. NEUROLOGY , 57 (12) 2191 - 2197.

Molyneux, PD; Kappos, L; Polman, C; Pozzilli, C; Barkhof, F; Filippi, M; Yousry, T; (2000) The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. BRAIN , 123 2256 - 2263.

Montalban, X; Sastre-Garriga, J; Filippi, M; Khaleeli, Z; Tellez, N; Vellinga, MM; Tur, C; (2009) Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. MULT SCLER , 15 (12) 1459 - 1465. 10.1177/1352458509348422.

Montalban, X; Thompson, AJ; (2002) Workshop on primary progressive multiple sclerosis: meeting summary. Multiple Sclerosis , 8 (2) 177 - 178.

Montalban, X; Tintore, M; Swanton, J; Barkhof, F; Fazekas, F; Filippi, M; Frederiksen, J; (2010) MRI criteria for MS in patients with clinically isolated syndromes. NEUROLOGY , 74 (5) 427 - 434. 10.1212/WNL.0b013e3181cec45c.

Morley, D; Selai, C; Schrag, A; Jahanshahi, M; Thompson, A; (2011) Adolescent and adult children of parents with Parkinson's disease: incorporating their needs in clinical guidelines. Parkinsons Dis , 2011 951874 - ?. 10.4061/2011/951874. Gold open access

Morley, D; Selai, C; Schrag, A; Thompson, AJ; Jahanshahi, M; (2010) Refinement and validation of the Parental Illness Impact Scale. PARKINSONISM RELAT D , 16 (3) 181 - 185. 10.1016/j.parkreldis.2009.11.001.

Morley, D; Selai, C; Thompson, A; (2012) The self-report Barthel Index: preliminary validation in people with Parkinson's disease. Eur J Neurol , 19 (6) 927 - 929. 10.1111/j.1468-1331.2011.03592.x.

Muhlert, N; Atzori, M; De Vita, E; Thomas, DL; Samson, RS; Wheeler-Kingshott, CA; Geurts, JJ; (2014) Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry , 85 (8) pp. 833-839. 10.1136/jnnp-2013-306662. Green open access
file

Muhlert, N; Atzori, M; De Vita, E; Thomas, DL; Samson, RS; Wheeler-Kingshott, CA; Geurts, JJ; (2014) Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. Journal of neurology, neurosurgery, and psychiatry , 85 (8) 833 - 839.

NAUTA, JJP; THOMPSON, AJ; BARKHOF, F; MILLER, DH; (1994) MAGNETIC-RESONANCE-IMAGING IN MONITORING THE TREATMENT OF MULTIPLE-SCLEROSIS PATIENTS - STATISTICAL POWER OF PARALLEL-GROUPS AND CROSSOVER DESIGNS. J NEUROL SCI , 122 (1) 6 - 14.

Nicholas, R; Playford, ED; Thompson, AJ; (2000) A retrospective analysis of outcome in severe Guillain-Barre syndrome following combined neurological and rehabilitation management. DISABIL REHABIL , 22 (10) 451 - 455.

O'Connor, R; Cano, SJ; Torrenta, LRI; Thompson, AJ; Playford, ED; (2005) Factors influencing work retention for people with multiple sclerosis - Cross-sectional studies using qualitative and quantitative methods. J NEUROL , 252 (8) 892 - 896. 10.1007/s00415-005-0765-4.

O'Connor, RJ; Cano, SJ; Thompson, AJ; Hobart, JC; (2004) Exploring rating scale responsiveness - Does the total score reflect the sum of its parts? NEUROLOGY , 62 (10) 1842 - 1844.

O'Connor, RJ; Cano, SJ; Thompson, AJ; Playford, ED; (2005) The impact of inpatient neurorehabilitation on psychological well-being on discharge and at 3 month follow-up. J NEUROL , 252 (7) 814 - 819. 10.1007/s00415-005-0751-x.

O'Farrelly, C; Kelly, J; Hekkens, W; Bradley, B; Thompson, A; Feighery, C; Weir, DG; (1983) Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) , 286 (6383) 2007 - 2010.

O'Riordan, JI; Losseff, NA; Phatouros, C; Thompson, AJ; Moseley, IF; MacManus, DG; McDonald, WI; (1998) Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J NEUROL NEUROSUR PS , 64 (3) 353 - 357.

O'Riordan, JI; Thompson, AJ; Kingsley, DPE; MacManus, DG; Kendall, BE; Rudge, P; McDonald, WI; (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS - A 10-year follow-up. BRAIN , 121 495 - 503.

ORiordan, JI; Gallagher, HL; Thompson, AJ; Howard, RS; Kingsley, DPE; Thompson, EJ; McDonald, WI; (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J NEUROL NEUROSUR PS , 60 (4) 382 - 387.

O’Connor, R.J.; Cano, S.J.; Thompson, A.J.; Hobart, J.C.; (2004) Exploring rating scale responsiveness: does the total score reflect the sum of its parts? Neurology , 62 (10) pp. 1842-1844.

Panchani, J; Adjei, P; Henneberger, C; Scott, CA; Thompson, AJ; Diehl, B; Walker, MC; (2011) Asymmetric hemispheric representation of periictal heart rate modulation is individually lateralised. EPILEPTIC DISORD , 13 (2) 172 - 176. 10.1684/epd.2011.0430.

Papadopoulos, K; Tozer, DJ; Fisniku, L; Altmann, DR; Davies, G; Rashid, W; Thompson, AJ; (2010) T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis. MULT SCLER , 16 (4) 427 - 433. 10.1177/1352458509359924.

Papadopoulos, K; Tozer, DJ; Fisniku, L; Altmann, DR; Davies, G; Rashid, W; Thompson, AJ; (2010) TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Mult Scler , 16 (4) 427 - 433. 10.1177/1352458509359924.

Patti, F; Ciancio, MR; Cacopardo, M; Reggio, E; Fiorilla, T; Palermo, F; Reggio, A; (2003) Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients - A randomised controlled trial. J NEUROL , 250 (7) 861 - 866. 10.1007/s00415-003-1097-x.

Paty, DW; Goodkin, D; Thompson, A; Rice, G; (1996) Guidelines for physicians with patients on IFN beta-1b: The use of an assay for neutralizing antibodies (NAB). NEUROLOGY , 47 (4) 865 - 866.

Penny, S; Khaleeli, Z; Cipolotti, L; Thompson, A; Ron, M; (2010) Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. NEUROLOGY , 74 (7) 545 - 552.

Pfennings, L; Cohen, L; Miller, D; Gerbaud, L; Vleugels, L; Freeman, J; Vernay, D; (1999) Using the short form-36 with multiple sclerosis patients in five countries: A cross-cultural comparison. PSYCHOL REP , 85 (1) 19 - 31.

Playford, ED; Sachs, R; Thompson, AJ; (2002) Integrated care pathways: outcome from inpatient rehabilitation following nontraumatic spinal cord lesion. CLIN REHABIL , 16 (3) 269 - 275. 10.1191/0269215502cr490oa.

Polman, C; Kappos, L; White, R; Dahlke, F; Beckmann, K; Pozzilli, C; Thompson, A; (2003) Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. NEUROLOGY , 60 (1) 37 - 43.

Polman, CH; Dahlke, F; Thompson, AJ; Ghazi, M; Kappos, L; Miltenburger, C; Pozzilli, C; (1995) Inteferon beta-1b in secondary progressive multiple sclerosis - outline of the clinical trial. Multiple Sclerosis , 1 S51 - S54.

Polman, CH; Kappos, L; Dahlke, F; Graf, R; Beckmann, K; Bogumil, T; Pozzilli, C; (2005) Interferon beta-1b treatment does not induce autoantibodies. NEUROLOGY , 64 (6) 996 - 1000.

Polman, CH; Kappos, L; Petkau, J; Thompson, A; (2003) Neutralising antibodies to interferon beta during the treatment of multiple sclerosis. J NEUROL NEUROSUR PS , 74 (8) 1162 - 1162.

Polman, CH; Miller, DH; McDonald, WI; Thompson, AJ; (1999) Treatment recommendations for interferon-beta in multiple sclerosis. J NEUROL NEUROSUR PS , 67 (5) 561 - 564.

Polman, CH; Petkau, J; Thompson, A; Dahlke, F; Kappos, L; (2003) Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b - Reply. NEUROLOGY , 61 (7) 1025 - 1025.

Polman, CH; Reingold, SC; Banwell, B; Clanet, M; Cohen, JA; Filippi, M; Fujihara, K; (2011) Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. ANN NEUROL , 69 (2) 292 - 302. 10.1002/ana.22366.

Polman, CH; Reingold, SC; Barkhof, F; Calabresi, PA; Clanet, M; Cohen, JA; Cutter, GR; (2008) Ethics of placebo-controlled clinical trials in multiple sclerosis - A reassessment. NEUROLOGY , 70 (13) 1134 - 1140.

Polman, CH; Reingold, SC; Edan, G; Filippi, M; Hartung, HP; Kappos, L; Lublin, FD; (2005) Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria". ANN NEUROL , 58 (6) 840 - 846. 10.1002/ana.206703.

Porter, B; Keenan, E; Record, E; Thompson, AJ; (2003) Diagnosis of MS: a comparison of three different clinical settings. MULT SCLER , 9 (5) 431 - 439. 10.1191/1352458503ms940oa.

Porter, B; Thompson, A; (2012) Connecting to the future--the promise of telecare. Mult Scler , 18 (4) 384 - 386. 10.1177/1352458512441273.

Pryce, G; Ahmed, Z; Hankey, DJR; Jackson, SJ; Croxford, JL; Pocock, JM; Ledent, C; (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. BRAIN , 126 2191 - 2202. 10.1093/brain/awg224.

Pryce, G; Visintin, C; Ramagopalan, SV; Al-Izki, S; De Faveri, LE; Nuamah, RA; Mein, CA; (2014) Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists. FASEB J , 28 (1) 117 - 130. 10.1096/fj.13-239442.

Pryce, G.; Ahmed, Z.; Hankey, D.J.R.; Jackson, S.J.; Croxford, J.L.; Pocock, J.M.; Ledent, C.; (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain , 126 (10) pp. 2191-2202. 10.1093/brain/awg224.

RAKHIT, RD; BECK, R; FOSTER, O; THOMPSON, AJ; KENDALL, B; (1993) RESOLUTION OF LOWER-LIMB NEUROLOGICAL DEFICIT WITH PENILE PAPAVERINE IN SPINAL ARTERIOVENOUS MALFORMATION. LANCET , 341 (8843) 490 - 490.

REVESZ, T; KIDD, D; THOMPSON, AJ; BARNARD, RO; MCDONALD, WI; (1994) A COMPARISON OF THE PATHOLOGY OF PRIMARY AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS. BRAIN , 117 759 - 765.

ROSSITER, D; THOMPSON, AJ; (1995) INTRODUCTION OF INTEGRATED CARE PATHWAYS FOR PATIENTS WITH MULTIPLE-SCLEROSIS IN AN INPATIENT NEUROREHABILITATION SETTING. DISABIL REHABIL , 17 (8) 443 - 448.

Rakusa, M; Cano, SJ; Porter, B; Riazi, A; Thompson, AJ; Chataway, J; Hardy, TA; (2015) A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses. PLoS One , 10 (3) e0120829 - ?. 10.1371/journal.pone.0120829.

Ramdharry, GM; Marsden, JF; Day, BL; Thompson, AJ; (2006) De-stabilizing and training effects of foot orthoses in multiple sclerosis. MULT SCLER , 12 (2) 219 - 226. 10.1191/135248506ms1266oa.

Ramio-Torrenta, L; Sastre-Garriga, J; Ingle, GT; Davies, GR; Ameen, V; Miller, DH; Thompson, AJ; (2006) Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J NEUROL NEUROSUR PS , 77 (1) 40 - 45. 10.1136/jnnp.2004.052316. Gold open access

Ramnani, N; Behrens, TEJ; Johansen-Berg, H; Richter, MC; Pinsk, MA; Andersson, JLR; Rudebeck, P; (2006) The evolution of prefrontal inputs to the cortico-pontine system: Diffusion imaging evidence from macaque monkeys and humans. CEREB CORTEX , 16 (6) 811 - 818. 10.1093/cercor/bhj024.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; Kapoor, R; (2006) Upper cervical cord area in early relapsing-remitting multiple sclerosis: Cross-sectional study of factors influencing cord size. J MAGN RESON IMAGING , 23 (4) 473 - 476. 10.1002/jmri-i.20545.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; Kapoor, R; (2006) Upper cervical cord area in early relapsing-remitting multiple sclerosis: Cross-sectional study of factors influencing cord size. J MAGN RESON IMAGING , 23 (4) 473 - 476. 10.1002/jmri-i.20545.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; Thompson, AJ; (2006) Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J NEUROL NEUROSUR PS , 77 (1) 51 - 55. 10.1136/jnnp.2005.068338. Gold open access

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Thompson, AJ; Miller, DH; (2007) Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study. MULT SCLER , 13 (2) 178 - 185. 10.1177/1352458506070758.

Rashid, W; Hadjiprocopis, A; Davies, G; Griffin, C; Chard, D; Tiberio, M; Altmann, D; (2008) Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. J NEUROL , 255 (3) 390 - 397. 10.1007/s00415-008-0678-0.

Rashid, W; Hadjiprocopis, A; Griffin, CM; Chard, DT; Davies, GR; Barker, GJ; Tofts, PS; (2004) Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction. MULT SCLER , 10 (1) 9 - 15. 10.1191/1352458504ms985oa.

Rashid, W; Parkes, LM; Ingle, GT; Chard, DT; Toosy, AT; Altmann, DR; Symms, MR; (2004) Abnormalities of cerebral perfusion in multiple sclerosis. J NEUROL NEUROSUR PS , 75 (9) 1288 - 1293. 10.1136/jnnp.2003.026021.

Redmond, J; Thompson, A; Hutchinson, M; (1983) Acute central cervical cord injury due to disco dancing. Br Med J (Clin Res Ed) , 286 (6379) 1704 - ?.

Reingold, SC; Steiner, JP; Polman, CH; Cohen, JA; Freedman, MS; Kappos, L; Thompson, AJ; (2009) The challenge of follow-on biologics for treatment of multiple sclerosis. NEUROLOGY , 73 (7) 552 - 559. 10.1212/WNL.0b013e3181b2a6ce.

Rejdak, K; Leary, SM; Nelissen, I; Opdenakker, G; Dubois, B; Thompson, AJ; Giovannoni, G; (2004) Urinary neopterin is a sensitive marker of longitudinal interferon beta-1a treatment in primary progressive multiple sclerosis patients. EUR J NEUROL , 11 120 - 120.

Rejdak, K; Leary, SM; Petzold, A; Thompson, AJ; Miller, DH; Giovannoni, G; (2010) Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis. MULT SCLER , 16 (9) 1066 - 1072. 10.1177/1352458510375100.

Riazi, A; Hobart, JC; Fitzpatrick, R; Freeman, JA; Thompson, AJ; (2003) Socio-demographic variables are limited predictors of health status in multiple sclerosis. J NEUROL , 250 (9) 1088 - 1093. 10.1007/s00415-003-0160-y.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Freeman, JA; Jenkinson, C; Peto, V; (2003) Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. J NEUROL NEUROSUR PS , 74 (6) 710 - 714.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2003) Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. MULT SCLER J , 9 (4) 411 - 419. 10.1191/1352458503ms929oa.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2002) Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry , 73 (6) 701 - 704.

Riazi, A; Porter, B; Chataway, J; Thompson, AJ; Hobart, JC; (2011) A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS). HEALTH QUAL LIFE OUT , 9 , Article 80. 10.1186/1477-7525-9-80. Gold open access

Riazi, A; Thompson, AJ; Hobart, JC; (2004) Self-efficacy predicts self-reported health status in multiple sclerosis. MULT SCLER , 10 (1) 61 - 66. 10.1191/1352458504ms986oa.

Richardson, D; Edwards, S; Sheean, GL; Greenwood, RJ; Thompson, AJ; (1997) The effect of botulinum toxin on hand function after incomplete spinal cord injury at the level of C5/6: a case report. CLIN REHABIL , 11 (4) 288 - 292.

Richardson, D; Greenwood, R; Sheean, G; Thompson, A; Edwards, S; (2000) Treatment of focal spasticity with botulinum toxin: effect on the 'positive support reaction'. Physiother Res Int , 5 (1) 62 - 70.

Richardson, D; Sheean, G; Werring, D; Desai, M; Edwards, S; Greenwood, R; Thompson, A; (2000) Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J NEUROL NEUROSUR PS , 69 (4) 499 - 506.

Richardson, D; Thompson, AJ; (1999) Botulinum toxin: its use in the treatment of acquired spasticity in adults. Physiotherapy , 85 (10) 541 - 551.

Richardson, D; Thompson, AJ; (1999) Management of spasticity in hereditary spastic paraplegia. Physiotherapy Research International , 4 (1) 68 - 76.

Rocca, MA; Absinta, M; Valsasina, P; Ciccarelli, O; Marino, S; Rovira, A; Gass, A; (2009) Abnormal Connectivity of the Sensorimotor Network in Patients With MS: A MultiCenter fMRI Study. HUM BRAIN MAPP , 30 (8) 2412 - 2425. 10.1002/hbm.20679.

Rocca, MA; Absinta, M; Valsasina, P; Ciccarelli, O; Marino, S; Rovira, A; Gass, A; (2009) Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study. Human Brain Mapping , 30 (8) 2412 - 2425. 10.1002/hbm.20679.

Rocca, MA; Agosta, F; Sormani, MP; Fernando, K; Tintore, M; Korteweg, T; Tortorella, P; (2008) A three-year, multi-parametric MRI study in patients at presentation with CIS. J NEUROL , 255 (5) 683 - 691. 10.1007/s00415-008-0776-z.

Rossiter, D; Thompson, AJ; (1995) Integrated care pathways and their role in the clinical audit of rehabilitation for people with multiple sclerosis. MS Management , 2 (2) 1, 9 - 1,18.

Rossiter, DA; Edmondson, A; Al-Shahi, R; Thompson, AJ; (1998) Integrated care pathways in multiple sclerosis rehabilitation: completing the audit cycle. MULT SCLER , 4 (2) 85 - 89.

Rovaris, M; Barkhof, F; Calabrese, M; De Stefano, N; Fazekas, F; Miller, DH; Montalban, X; (2009) MRI features of benign multiple sclerosis Toward a new definition of this disease phenotype. NEUROLOGY , 72 (19) 1693 - 1701. 10.1212/WNL.0b013e3181a55feb.

Rovaris, M; Barnes, D; Woodrofe, N; duBoulay, GH; Thorpe, JW; Thompson, AJ; McDonald, WI; (1996) Patterns of disease activity in multiple sclerosis patients: A study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J NEUROL , 243 (7) 536 - 542.

Rovaris, M; Judica, E; Sastre-Garriga, J; Rovira, A; Sormani, MP; Benedetti, B; Korteweg, T; (2008) Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. MULT SCLER , 14 (4) 455 - 464. 10.1177/1352458507085129.

Rozewicz, L; Langdon, DW; Davie, CA; Thompson, AJ; Ron, M; (1996) Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case report. Cogn Neuropsychiatry , 1 (1) 17 - 26. 10.1080/135468096396677.

Rudick, R; Antel, J; Confavreux, C; Cutter, G; Ellison, G; Fischer, J; Lublin, F; (1997) Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. ANN NEUROL , 42 (3) 379 - 382.

Rudick, R; Antel, J; Confavreux, C; Cutter, G; Ellison, G; Fischer, J; Lublin, F; (1996) Clinical outcomes assessment in multiple sclerosis. Ann Neurol , 40 (3) 469 - 479. 10.1002/ana.410400321.